A lesson in humility: the added values of PET-MRI over PET-CT in detecting malignant hepatic lesions.

Dan Cohen Mikhail Kesler Marina Muchnik Kurash Einat Even-Sapir Charles Levine

Published in: European journal of nuclear medicine and molecular imaging (2023)

PET-MRI offers several advantages over PET-CT in assessing the extent and response to therapy of malignant hepatic involvement. Additional malignant lesions detected on PET-MRI are attributed to superior PET performance (compared with PET of PET-CT), greater spatial resolution provided by MRI, and improved multi-parametric viability assessment. In around one-tenth of cases, findings identified on PET-MRI but not on PET-CT significantly change the final report's conclusion.

Keyphrases

pet ct
contrast enhanced
magnetic resonance imaging
positron emission tomography
diffusion weighted imaging
computed tomography
magnetic resonance
bone marrow
smoking cessation
replacement therapy
chemotherapy induced